BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20027)

  • 21. Statistical analysis of histomorphological findings in medullary thyroid carcinoma: distinction between the different familial forms of the disease. G.E.T.C. Groupe d'Etude des Tumeurs a Calcitonine.
    Franc B; Rosenberg-Bourgin M; Auvert B; Caillou B; Dutrieux-Berger N; Floquet J; Houcke-Lecomte M; Justrabo E; Labat-Moleur F; Le Bodic MF
    Henry Ford Hosp Med J; 1992; 40(3-4):261-3. PubMed ID: 1362419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medullary thyroid carcinoma.
    Leboulleux S; Baudin E; Travagli JP; Schlumberger M
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):299-310. PubMed ID: 15355445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.
    Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
    Oncogene; 2006 Feb; 25(5):677-84. PubMed ID: 16205644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of individual tumor syndromes. Medullary thyroid carcinoma and hyperparathyroidism.
    Snow KJ; Boyd AE
    Endocrinol Metab Clin North Am; 1994 Mar; 23(1):157-66. PubMed ID: 7913022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience with presymptomatic screening of patients with C cell carcinoma of the thyroid gland].
    Frilling A; Röher HD; Ponder BA; Goretzki PE; Schlaghecke R; Reiners C
    Chirurg; 1993 Jan; 64(1):28-35. PubMed ID: 8094664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association between medullary carcinoma of the thyroid and pathology of the parathyroid glands. Pathogenetic significance, diagnosis and treatment in a series of 13 patients].
    Pansini GC; degli Uberti E; Trasforini G; Scalco GB; Carrella G; Mascoli F; Fabi P; De Anna D; Ortolani M; Liboni A
    Minerva Chir; 1986 Dec; 41(23-24):1971-80. PubMed ID: 2881230
    [No Abstract]   [Full Text] [Related]  

  • 27. [Multiple endocrine neoplasia-type medullary thyroid carcinoma in three generations of a family].
    Takácsi NZ; Poller I; Trón L; Dabasi G; Rákóczy G; Füzy M; Szentirmay Z; Esik O
    Orv Hetil; 1998 Nov; 139(48):2883-8. PubMed ID: 9868902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic usefulness of the calcitonin secretion induced with pentagastrin in the familial medullary thyroid carcinoma.
    González-Villalpando C; Madero A; Peña J; Ramírez R; Szymansky J; Ruiz JE; Zárate A
    Arch Invest Med (Mex); 1985; 16(3):237-45. PubMed ID: 2870690
    [No Abstract]   [Full Text] [Related]  

  • 29. [Usefulness of calcitonin measurement for the diagnosis of medullary cancer of the thyroid in a family with multiple endocrine adenoma syndrome of type IIB].
    Pumarino H; Riesco J; Michelsen H; Campino C; Cembal J; Generini G
    Rev Med Chil; 1984 Jul; 112(7):675-80. PubMed ID: 6151224
    [No Abstract]   [Full Text] [Related]  

  • 30. [Medullary thyroid carcinoma--familial or sporadic disease?].
    Høie J; Jørgensen OG; Nesland JM; Møller P; Bjøro K
    Tidsskr Nor Laegeforen; 1994 Oct; 114(25):2951-4. PubMed ID: 7974404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
    Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
    Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of medullary thyroid carcinomas.
    Hamoir M; Maisin JP; Warnier P; Ketelslegers JM; Rahier J
    Acta Otorhinolaryngol Belg; 1987; 41(5):782-92. PubMed ID: 2899945
    [No Abstract]   [Full Text] [Related]  

  • 33. Mineral metabolic effects of thyroidectomy and long-term outcomes in a family with MEN 2A.
    Bone HG; Deftos LJ; Snyder WH; Pak CY
    Henry Ford Hosp Med J; 1992; 40(3-4):258-60. PubMed ID: 1362418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Medullary carcinoma of the thyroid: a case of multiple endocrine neoplasia type 2A].
    Pati M; Sperti P; Magiar AV; Bonifacio V
    Minerva Endocrinol; 1994 Mar; 19(1):29-32. PubMed ID: 7913514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late-onset medullary carcinoma of the thyroid: need for genetic testing and prophylactic thyroidectomy in adult family members.
    Shaha AR; Cohen T; Ghossein R; Tuttle RM
    Laryngoscope; 2006 Sep; 116(9):1704-7. PubMed ID: 16955009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Medullary carcinoma of the thyroid gland and the APUD system].
    Neradilová M
    Cesk Pediatr; 1992 Aug; 47(8):492-6. PubMed ID: 1356639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma: Turkish experience.
    Erdogan MF; Gursoy A
    Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():503-7. PubMed ID: 17551473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Familial studies in medullary thyroid carcinoma and multiple endocrine adenomatosis].
    Woodtli W; Ziegler WH; Dambacher MA
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1780-4. PubMed ID: 6129697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medullary (solid) carcinoma of the thyroid gland: an analysis of the M. D. Anderson hospital experience with patients with the tumor, its special features, and its histogenesis.
    Hill CS; Ibanez ML; Samaan NA; Ahearn MJ; Clark RL
    Medicine (Baltimore); 1973 Mar; 52(2):141-71. PubMed ID: 4695843
    [No Abstract]   [Full Text] [Related]  

  • 40. Medullary carcinoma of the thyroid.
    Hollenberg CH
    Arch Otolaryngol; 1983 Feb; 109(2):103-5. PubMed ID: 6849663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.